Flowchart showing screening and multi-step selection procedure for collection of information and cord blood. Table A, Cell surface markers used for fluorochrome-labeled monoclonal antibody cocktails.
a36 patients who were not included in the Stage Two study aged from 18 to 61 (mean 40.1 [SD 12.1]). 31 (86%) were male and 28 (78%) were from rural area. 20 (56%) were unreachable due to moving and ot
